The Structure‐Based Design of Mdm2/Mdmx–p53 Inhibitors Gets Serious (Q37845797)
scientific article published on February 21, 2011
Language:
(P31) (Q13442814)
(P50) (Q87710372)
(Q73024340)
(P304) 2680-2688
(P407) (Q1860)
(P433) 12
(P478) 50
(P577) Monday, February 21, 2011
(P953) https://europepmc.org/articles/pmc3113661?pdf=render
https://europepmc.org/articles/PMC3113661
https://europepmc.org/articles/PMC3113661?pdf=render
https://doi.org/10.1002/anie.201003863
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fanie.201003863
https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201003863
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/anie.201003863
(P1433) (Q62023953)
(P1476) "The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious" (language: en)
"The Structure‐Based Design of Mdm2/Mdmx–p53 Inhibitors Gets Serious" (language: en)
(P2093) Tad A. Holak
(P2860) (Q37719514)
(Q37700986)
(Q33533630)
(Q34020353)
(Q37680961)
(Q35014385)
(Q27658148)
(Q35206381)
(Q27657975)
(Q27657769)
(Q37602507)
(Q37597839)
(Q37591937)
(Q33499732)
(Q33937376)
(Q37526379)
(Q37508606)
(Q27653993)
(Q27653453)
(Q24651380)
(Q37261088)
(Q27651405)
(Q33337530)
(Q37137883)
(Q36499146)
(Q37017687)
(Q27648794)
(Q24294074)
(Q36824997)
(Q36094618)
(Q29619939)
(Q29616243)
(Q29618727)
(Q36717697)
(Q34593294)
(Q29615658)
(Q36663493)
(Q36184746)
(Q33211997)
(Q28611384)
(Q27642888)
(Q29618133)
(Q24314763)
(Q39736810)
(Q39742276)
(Q39896539)
(Q40244145)
(Q40294895)
(Q40325988)
(Q47440423)
(Q45772787)
(Q46197811)
(Q51057558)
(Q46608003)
(Q74247134)
(Q79141178)
(Q81989507)
(Q83078001)
(P13046) (Q7318358)
other details
description scientific article published on February 21, 2011

External Links